Poor “Site Effect” Profile? Neurochem Reports Inconclusive Alzheimer’s Data For Alzhemed
This article was originally published in The Pink Sheet Daily
Executive Summary
Canadian firm will base Alzhemed next steps on Special Advisory Board analysis of North American trial data.